TWINBEECH CAPITAL LP

Position in TVTX — Travere Therapeutics, Inc.

CIK 1769646 PURCHASE, NY

Position in TVTX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$1,512,239

+$820,635 QoQ

Shares Held

50,900

+8.9% QoQ

Ownership

0.055%

of shares outstanding

% of Portfolio

0.16%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2022

11 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

TWINBEECH CAPITAL LP holds $33,258,211 across 31 Biotechnology names. TVTX ranks #7 (4.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PCVX	Vaxcyte, Inc.	65,900	$3,829,449
2	TECH	BIO-TECHNE Corp	56,400	$2,947,464
3	SNDX	Syndax Pharmaceuticals Inc	90,006	$2,102,540
4	ADMA	Adma Biologics, Inc.	221,841	$1,998,787
5	VKTX	Viking Therapeutics, Inc.	56,100	$1,825,494
6	MRNA	Moderna, Inc.	34,668	$1,761,134
7	TVTX	Travere Therapeutics, Inc. This page	50,900	$1,512,239
8	VRDN	Viridian Therapeutics, Inc.\DE	76,884	$1,503,851

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,512,239	50,900	+8.9%	Shares	Sole	2026-05-15
2025-06-30	$691,604	46,730	-72.8%	Shares	Sole	2025-08-14
2025-03-31	$3,081,326	171,949	+1590.9%	Shares	Sole	2025-05-15
2024-12-31	$177,143	10,169	-30.9%	Shares	Sole	2025-02-14
2024-03-31	$113,475	14,718	-28.5%	Shares	Sole	2024-05-15
2023-12-31	$184,987	20,577	-91.0%	Shares	Sole	2024-02-14
2023-09-30	$2,045,346	228,786	+33.1%	Shares	Sole	2023-11-14
2023-06-30	$2,639,554	171,846	+29.6%	Shares	Sole	2023-08-14
2023-03-31	$2,982,803	132,628	+377.5%	Shares	Sole	2023-05-15
2022-12-31	$584,066	27,773	-63.7%	Shares	Sole	2023-02-14
2022-09-30	$1,887,522	76,604	—	Shares	Sole	2022-11-14
No filing history on record for this holder in this stock.